GO:0006452 translational frameshifting: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006452 translational frameshifting is a biological process in which a single mRNA is decoded in more than one reading frame, producing different proteins from the same transcript.
• Programmed frameshifting is used by many viruses and some cellular genes to regulate the ratio of two proteins from one mRNA, such as the classic gag-pol polyprotein of retroviruses.
• Frameshifting can be stimulated by mRNA signals including slippery heptamer sequences, downstream stem-loops or pseudoknots, and by ribosome pausing or collisions.
• N1-methylpseudouridylation of mRNA, used in some vaccines, can cause +1 ribosomal frameshifting and unintended protein products.
• Frameshifting and repeat-associated non-AUG translation contribute to human neurodegenerative disorders such as fragile X-associated tremor/ataxia syndrome and C9orf72-linked amyotrophic lateral sclerosis.
• CRISPR-based knockout, point-mutation, knock-in and overexpression models allow causal testing of frameshifting signals and trans-acting factors.
Description
Translational frameshifting (GO:0006452) is a biological process in which the ribosome changes the reading frame while translating an mRNA, so that a single transcript can yield more than one protein product. Instead of maintaining the standard three-nucleotide codon register, the ribosome may shift by one nucleotide (-1 or +1) at a specific site, and the new frame is then translated to a different stop codon or functional domain. This process is widespread in viruses and is also found in cellular genes, where it can act as a regulatory mechanism. Because frameshifting changes the proteome without changing the transcriptome, it is of direct interest to researchers studying gene expression, viral replication and mRNA therapeutics. The QuickGO definition states that translational frameshifting is a mechanism whereby different proteins may result from a single mRNA molecule, due to a change in the parsing of three nucleotides per codon relative to an initiating AUG codon. This article summarizes the mechanism, the genes and signals involved, the diseases linked to frameshifting, and the experimental methods used to study it.
translational frameshifting At A Glance
| GO ID | GO:0006452 |
|---|---|
| GO term | translational frameshifting |
| Ontology | biological_process |
| Synonym | none listed in QuickGO |
| Major function | Allows different proteins to be produced from a single mRNA by changing the reading frame during translation |
| Definition source | QuickGO definition: a mechanism whereby different proteins may result from a single mRNA molecule, due to a change in the parsing of three nucleotides per codon relative to an initiating AUG codon |
| Typical triggers | Slippery heptamer sequences, downstream stem-loops or pseudoknots, and ribosome pausing or collisions |
| Directionality | Can be -1 or +1 depending on the mRNA signal and the organism |
| Disease relevance | Linked to viral replication, neurodegenerative repeat disorders and mRNA therapeutic side effects |
What Is GO:0006452?
In simple terms, translational frameshifting is a programmed change in how the ribosome groups mRNA nucleotides into codons, so that one mRNA can be read in more than one frame and produce different proteins. The process is usually site-specific and is triggered by cis-acting mRNA elements, such as a slippery sequence and a downstream RNA structure, often combined with ribosome pausing. Frameshifting can be -1 or +1, and it is distinct from ordinary recoding events such as stop-codon readthrough because it changes the reading frame itself. The result is a single mRNA that encodes a fusion protein or two separate proteins, which is a common strategy in viral gene expression and an emerging consideration in mRNA therapeutics.
Why Is translational frameshifting Important in Cell Biology?
Translational frameshifting is important because it expands the coding capacity of genomes and provides a fast, post-transcriptional way to regulate protein ratios without changing mRNA levels. In viruses, frameshifting controls the production of essential enzymes such as reverse transcriptase and protease from a single gag-pol mRNA, making it a validated antiviral target. In human disease, frameshifting and related recoding events contribute to repeat-associated neurodegeneration and can be triggered by chemical modifications in therapeutic mRNA. For researchers, frameshifting is also a model system for understanding how the ribosome maintains translational frame, a fundamental question in molecular biology.
• Provides a mechanism for producing multiple proteins from one mRNA, increasing coding efficiency.
• Essential for the replication of many RNA viruses, including retroviruses and coronaviruses.
• Regulates the ratio of structural and enzymatic viral proteins, which is critical for virion assembly.
• Contributes to human neurodegenerative disorders through repeat-associated non-AUG translation and frameshifting.
• Can be induced by N1-methylpseudouridylation of therapeutic mRNA, raising safety and quality-control questions.
• Serves as a paradigm for studying translational frame maintenance and ribosome dynamics.
• Is modulated by ribosome collisions, linking translation stress to recoding outcomes.
• Offers targets for antiviral and gene-expression-modulating therapies.
• Requires careful experimental design because frameshifting efficiency is context-dependent.
• Can be studied with CRISPR models to test the causal role of specific mRNA signals and trans factors.
What Happens During translational frameshifting?
Recognition of the frameshifting signal
In simple terms: The ribosome first encounters a special sequence in the mRNA that tells it to change frame.
Programmed frameshifting typically begins when the translating ribosome reaches a cis-acting signal in the mRNA, most commonly a slippery heptamer followed by a downstream stimulatory structure such as a stem-loop or pseudoknot. These elements are sufficient to direct frameshifting in reporter assays, and their strength determines the efficiency of the shift. In cellular genes, analogous signals have been identified, for example in the Saccharomyces cerevisiae YPL034W gene, where a conserved +1 frameshifting event occurs.
Ribosome pausing and collision
In simple terms: The ribosome slows down at the signal, which gives it time to slip into a new frame.
Frameshifting is often promoted by ribosome pausing, which can be caused by rare codons, stable RNA structures, or collisions with a downstream ribosome. Smith et al. showed that ribosome collisions alter frameshifting at translational reprogramming motifs in bacterial mRNAs, indicating that the local traffic of ribosomes is a determinant of frameshifting efficiency. This pausing is thought to increase the time available for the ribosome to sample alternative frames.
The shift in reading frame
In simple terms: The ribosome slips by one nucleotide and starts reading the mRNA in a different triplet pattern.
At the slippery sequence, the ribosome and its tRNAs can shift by one nucleotide in either the -1 or +1 direction, after which decoding continues in the new frame. The shift changes the meaning of all downstream codons and usually leads to a different C-terminal protein sequence, often a fusion with an enzymatic domain. The exact direction and efficiency depend on the sequence context and the availability of matching tRNAs.
Elongation and termination in the new frame
In simple terms: After the shift, the ribosome finishes the protein using the new frame until it hits a stop codon.
Once the frame has shifted, the ribosome continues elongation in the new register until it reaches a stop codon, producing a protein with a different C-terminus from the product of the original frame. In retroviruses, this yields the gag-pol fusion protein, which is then processed into active enzymes. In cellular genes, the frameshifted product can have a distinct function or localization, as seen for the conserved +1 frameshifting in YPL034W.
Regulation and quality control
In simple terms: Cells and viruses can tune how often the shift happens, and quality-control pathways can respond to the products.
Frameshifting efficiency can be modulated by trans-acting factors, tRNA abundance, and the translation environment, including ribosome collisions and stress. In mRNA therapeutics, the incorporation of N1-methylpseudouridine can cause +1 ribosomal frameshifting, leading to unintended protein products that may affect immunogenicity or efficacy. These observations highlight the need for careful sequence design and quality control in mRNA-based applications.
Key Genes Involved in GO:0006452 translational frameshifting
The following genes and proteins are experimentally linked to translational frameshifting or its regulation, based on the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| gag-pol (retroviral) | Encodes the polyprotein produced by -1 frameshifting | Classic model for programmed frameshifting and antiviral targeting |
| YPL034W (S. cerevisiae) | Cellular gene with conserved +1 frameshifting | Model for endogenous frameshifting in eukaryotes |
| PRRSV NSP2 | Viral protein studied in the context of PRRSV biology | Relevant to viral frameshifting and replication research |
| C9orf72 | Repeat expansion associated with RAN translation and frameshifting | Model for neurodegeneration-linked recoding |
| FMR1 | Repeat expansion linked to frameshifting and RAN translation | Model for fragile X-associated disorders |
| tRNA genes | Provide tRNAs that decode slippery codons | Modulate frameshifting efficiency |
| Ribosomal protein genes | Form the ribosome that maintains or shifts frame | Targets for studying frame maintenance |
| eEF2 | Translation elongation factor | Potential modulator of ribosome pausing and frameshifting |
| eIF5A | Translation factor implicated in elongation | Candidate regulator of recoding events |
| Upf1 | Nonsense-mediated decay factor | Quality-control factor for frameshifted products |
| Hsp70 chaperones | Protein folding and quality control | May influence stability of frameshifted proteins |
| Antizyme (OAZ1) | Cellular protein produced by +1 frameshifting | Model for regulated frameshifting in polyamine homeostasis |
| HIV-1 gag-pol | Viral polyprotein from -1 frameshifting | Antiviral target and model system |
| SARS-CoV-2 ORF1a/1b | Viral polyprotein from -1 frameshifting | Antiviral target and model system |
| PRF1 (plant) | Frameshifting element in plant viruses | Comparative model for plant-virus recoding |
| Ty1 retrotransposon | Yeast retrotransposon using +1 frameshifting | Genetic model for programmed frameshifting |
| YPL034W frameshift product | Cellular protein generated by +1 frameshifting | Functional study of endogenous frameshifting |
How Is translational frameshifting Regulated?
Translational frameshifting is regulated at multiple levels. Cis-acting mRNA elements, including slippery sequences and downstream structures, set the intrinsic efficiency of the shift. Trans-acting factors such as tRNA availability, elongation factors, and ribosome collisions modulate the probability of shifting in a given cellular context. In addition, mRNA modifications such as N1-methylpseudouridylation can alter frameshifting, linking chemical modification of mRNA to recoding outcomes. Stress conditions and quality-control pathways may further influence the stability of frameshifted products.
translational frameshifting and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| C9orf72 | Amyotrophic lateral sclerosis and frontotemporal dementia | Knock-in of repeat expansion in cell lines; RAN translation reporters |
| FMR1 | Fragile X-associated tremor/ataxia syndrome | Knock-in of CGG repeats; frameshifting reporter assays |
| HIV-1 gag-pol | Viral replication and AIDS | Viral frameshifting reporter; antiviral screening |
| SARS-CoV-2 ORF1a/1b | COVID-19 and coronavirus replication | Frameshifting reporter; antiviral screening |
| PRRSV NSP2 | Porcine reproductive and respiratory syndrome | Viral infection models; NSP2 expression studies |
Neurodegenerative repeat disorders
Repeat expansions in genes such as C9orf72 and FMR1 are associated with repeat-associated non-AUG (RAN) translation and frameshifting, producing toxic proteins that contribute to neurodegeneration. Wojciechowska et al. reviewed how RAN translation and frameshifting act as translational challenges at simple repeats in human neurodegenerative disorders. These mechanisms provide a link between mRNA sequence, translation fidelity, and disease pathology.
Viral replication and antiviral targets
Many RNA viruses depend on programmed frameshifting to produce essential enzymes from a single polyprotein precursor. For example, retroviruses and coronaviruses use -1 frameshifting to generate the gag-pol or ORF1a/1b polyproteins, and interfering with this event can reduce viral replication. Porcine reproductive and respiratory syndrome virus (PRRSV) biology, including NSP2, has been studied in this context.
mRNA therapeutics and vaccine safety
N1-methylpseudouridylation of mRNA, a modification used to reduce innate immune activation in mRNA vaccines, can cause +1 ribosomal frameshifting and the production of unintended proteins. Mulroney et al. demonstrated that this modification can lead to +1 frameshifting, highlighting the need to assess recoding in mRNA therapeutics. This has implications for the design and quality control of mRNA-based medicines.
From translational frameshifting-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate slippery sequence drive frameshifting? | Knock-in of the sequence into a reporter gene; dual-luciferase assay |
| Is a trans-acting factor required for frameshifting? | CRISPR knockout of the candidate gene followed by frameshifting reporter assay |
| Does a point mutation in the mRNA signal alter efficiency? | Point-mutation knock-in at the slippery site; Ribo-seq |
| Can a tagged frameshift product be tracked? | Tagged knock-in of the endogenous locus; imaging and proteomics |
| Does overexpression of a factor change frameshifting? | Overexpression cell model; reporter assay |
| What is the global impact of frameshifting on translation? | Ribo-seq and RNA-seq in wild-type and mutant cells |
How to Study the translational frameshifting Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Dual-luciferase reporter | Frameshifting efficiency at a defined signal | Testing slippery sequences and structures |
| Ribo-seq | Ribosome positions and reading frame genome-wide | Discovering endogenous frameshifting sites |
| RNA-seq | mRNA levels and sequence variants | Confirming transcript integrity in frameshifting studies |
| Mass spectrometry | Protein products and post-translational modifications | Detecting frameshifted proteins |
| CRISPR knockout | Loss-of-function of candidate trans factors | Testing requirement for frameshifting |
| CRISPR knock-in | Precise mutation of cis-elements | Testing point mutations in slippery sequences |
| Overexpression | Gain-of-function of candidate factors | Testing sufficiency in frameshifting |
| Imaging | Localization of tagged frameshift products | Tracking endogenous frameshift proteins |
Reporter assays for frameshifting efficiency
Dual-luciferase or fluorescent reporters containing the candidate slippery sequence and downstream structure are the standard method to measure frameshifting efficiency. These assays allow comparison of wild-type and mutant signals and can be used in CRISPR-edited cell lines.
Ribosome profiling (Ribo-seq)
Ribo-seq provides a genome-wide view of ribosome positions and can detect changes in reading frame, including frameshifting events. It is particularly useful for identifying endogenous frameshifting sites and for assessing the impact of mRNA modifications.
Proteomics and mass spectrometry
Mass spectrometry can identify frameshifted protein products and quantify their abundance, providing direct evidence that a shift occurs in cells. This is important for validating reporter-based findings and for studying viral polyprotein processing.
CRISPR-based genetic models
CRISPR knockout, point mutation, knock-in and overexpression models allow causal testing of cis-elements and trans-factors in frameshifting. These models are essential for linking frameshifting to cellular phenotypes and disease.
How CRISPR Can Be Used to Study GO:0006452 translational frameshifting
Knockout
CRISPR knockout of candidate genes can test whether a trans-acting factor is required for translational frameshifting. For example, knocking out a tRNA-modifying enzyme or a ribosomal protein gene can reveal its role in frame maintenance.
Point Mutation
Point-mutation knock-in at a slippery sequence or downstream structure can precisely test which nucleotides are required for frameshifting. This approach is valuable for dissecting the contribution of individual bases to recoding efficiency.
Knock-in
Knock-in of a reporter or tag at an endogenous frameshifting locus allows measurement of frameshifting in a native context. This can be combined with Ribo-seq to quantify the shift at the endogenous site.
Overexpression
Overexpression of candidate factors or of the frameshifting mRNA can test sufficiency and dose-dependence of frameshifting. This is useful for studying viral polyprotein production and cellular recoding.
How EDITGENE Supports translational frameshifting Research
Researchers studying translational frameshifting-related genes often need to determine whether a candidate gene is causally involved in the process or is merely correlated with it. CRISPR-based models provide a direct way to test causality by deleting, mutating, tagging or overexpressing the relevant sequences and factors.
Contact EDITGENE today to design your custom CRISPR model for translational frameshifting research.
Frequently Asked Questions About translational frameshifting
What is translational frameshifting (GO:0006452)?
Translational frameshifting is a biological process in which the ribosome changes reading frame on an mRNA, so that a single transcript can produce different proteins.
What genes are involved in translational frameshifting?
Genes include viral gag-pol and ORF1a/1b, cellular genes such as YPL034W, and factors such as tRNAs and ribosomal proteins.
How does programmed frameshifting work?
It is triggered by mRNA signals such as slippery sequences and downstream structures, often combined with ribosome pausing, leading to a -1 or +1 shift.
Why is translational frameshifting important for viruses?
Many viruses use frameshifting to produce essential enzymes from a single polyprotein mRNA, which is required for replication.
Can mRNA modifications cause frameshifting?
Yes, N1-methylpseudouridylation of mRNA can cause +1 ribosomal frameshifting and unintended protein products.
What diseases are linked to frameshifting?
Frameshifting and RAN translation are linked to neurodegenerative repeat disorders such as C9orf72-associated ALS and FMR1-associated disorders.
How do you measure frameshifting efficiency?
Reporter assays, Ribo-seq, and mass spectrometry are commonly used to measure frameshifting efficiency and products.
What is the difference between -1 and +1 frameshifting?
The ribosome shifts by one nucleotide in the -1 or +1 direction, changing the downstream reading frame and protein product.
Can CRISPR be used to study frameshifting?
Yes, CRISPR knockout, point mutation, knock-in and overexpression models can test the role of cis-elements and trans-factors in frameshifting.
What is the role of ribosome collisions in frameshifting?
Ribosome collisions can alter frameshifting at reprogramming motifs, linking translation traffic to recoding efficiency.
Conclusion
Translational frameshifting (GO:0006452) is a fundamental recoding mechanism that allows one mRNA to produce multiple proteins by changing the reading frame. It is essential for viral replication, contributes to neurodegenerative disease through repeat-associated translation, and has emerged as a safety consideration for mRNA therapeutics. Understanding its mechanism, regulation and disease links requires precise genetic models and quantitative methods such as Ribo-seq and reporter assays. CRISPR-based knockout, point-mutation, knock-in and overexpression approaches provide the causal evidence needed to move the field forward.
References
- 1. Farabaugh PJ. 1996. Programmed translational frameshifting.. Microbiol Rev 60(1):103-34 PMID: 8852897
- 2. Ivanov IP et al.. 2025. Conserved +1 translational frameshifting in the Saccharomyces cerevisiae gene encoding YPL034W.. J Biol Chem 301(12):110891 PMID: 41197732
- 3. Mulroney TE et al.. 2024. N(1)-methylpseudouridylation of mRNA causes +1 ribosomal frameshifting.. Nature 625(7993):189-194 PMID: 38057663
- 4. Farabaugh PJ. 2000. Translational frameshifting: implications for the mechanism of translational frame maintenance.. Prog Nucleic Acid Res Mol Biol 64:131-70 PMID: 10697409
- 5. Smith AM et al.. 2019. Ribosome collisions alter frameshifting at translational reprogramming motifs in bacterial mRNAs.. Proc Natl Acad Sci U S A 116(43):21769-21779 PMID: 31591196
- 6. Wojciechowska M et al.. 2014. RAN translation and frameshifting as translational challenges at simple repeats of human neurodegenerative disorders.. Nucleic Acids Res 42(19):11849-64 PMID: 25217582
- 7. Liu B et al.. 2023. Research Progress of Porcine Reproductive and Respiratory Syndrome Virus NSP2 Protein.. Viruses 15(12) PMID: 38140551
- 8. Dinman JD. 2012. Mechanisms and implications of programmed translational frameshifting.. Wiley Interdiscip Rev RNA 3(5):661-73 PMID: 22715123
